New ScientistEN
Personalised cancer vaccine expected to be approved next year
A bespoke vaccine that is tailored to target an individual's unique skin cancer reduced rates of recurrence or death in a late-stage trial, making an approval expected
Fresh headlines from around the world. Gaming, politics, technology and everything in between.
A bespoke vaccine that is tailored to target an individual's unique skin cancer reduced rates of recurrence or death in a late-stage trial, making an approval expected
The scientists involved say the results could mark a turning point in cancer treatment, bringing personalised medicine a step closer.
Allnira republishes accessible articles under owner-declared permissions, with original authors, publishers and image credits. Automatic cloud imports run hourly; open pages check for updates every 15 seconds. Publication delays depend on each feed.